An evaluation demonstrating continued efficacy and improved safety and tolerability in 17 patients switched to PEGASYS® after discontinuation from REBETRON™ for the treatment of chronic hepatitis C

✍ Scribed by R.P. Perrillo; K.D. Rothstein; I. Alam; P.J. Thuluvath; M. Palmer; P.J. Pockros; S.C. Pappas; B.S. Doerschuk; S. Cantwell

• Book ID: 119527361
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 132 KB
• Volume: 34
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(01)81406-9